BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 16835071)

  • 1. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 2. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

  • 3. HRT, HERS, NIH, WHI: alphabet soup?
    Legato MJ
    J Gend Specif Med; 2002; 5(6):10-3. PubMed ID: 12503220
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen plus progestin, benefits and risks: the "Women's Health Initiative" trials.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Mar; 14(2):157-60. PubMed ID: 15728959
    [No Abstract]   [Full Text] [Related]  

  • 5. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-think HRT: behind the scene of perceptions.
    Pines A
    Climacteric; 2008; 11(6):443-6. PubMed ID: 18991073
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical appraisal of the Women's Health Initiative.
    Speroff L
    J Obstet Gynaecol Res; 2005 Apr; 31(2):80-93. PubMed ID: 15771632
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormone replacement therapy and vessels: what's the story in 2007?].
    Chabbert-Buffet N
    J Mal Vasc; 2007 Dec; 32(4-5):190-1. PubMed ID: 17698308
    [No Abstract]   [Full Text] [Related]  

  • 9. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 10. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's cognitive health: postmenopausal dementia and the women's health initiative memory study.
    Klein KP; Rapp SR
    Womens Health Issues; 2004; 14(3):71-4. PubMed ID: 15193634
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users.
    Lawton B; Rose S; McLeod D; Dowell A
    BMJ; 2003 Oct; 327(7419):845-6. PubMed ID: 14551101
    [No Abstract]   [Full Text] [Related]  

  • 13. Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned.
    Harv Womens Health Watch; 2006 May; 13(9):1-4. PubMed ID: 16696133
    [No Abstract]   [Full Text] [Related]  

  • 14. Women's health issues.
    Kaiser FE
    Med Clin North Am; 2003 Sep; 87(5):xi-xiii. PubMed ID: 14621323
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
    Wittes J; Barrett-Connor E; Braunwald E; Chesney M; Cohen HJ; Demets D; Dunn L; Dwyer J; Heaney RP; Vogel V; Walters L; Yusuf S
    Clin Trials; 2007; 4(3):218-34. PubMed ID: 17715247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income.
    Wei F; Miglioretti DL; Connelly MT; Andrade SE; Newton KM; Hartsfield CL; Chan KA; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):106-12. PubMed ID: 16287895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone therapy and cardiovascular disease in women.
    Stefanick ML
    Nutr Metab Cardiovasc Dis; 2010 Jul; 20(6):451-8. PubMed ID: 20554177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.